Tag: caplacizumab-yhdp

Home / caplacizumab-yhdp

Categories

Caplacizumab-yhdp approved by FDA

On February 6, 2019, in conjunction with plasma exchange and immunosuppressive treatment, the Food and Drug Administration approved caplacizumab-yhdp (CABLIVI, Ablynx NV) for adult patients with acqui...
caplacizumab-yhdp

Scan the code